Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OlyCAR-019 in r/r B-Cell Malignancies
NCT05932173Phase 2Unknown
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of OlyCAR-019 in B-cell leukemia (BCL), B cell lymphoma. Status: unknown.
02
Drugs
OlyCAR-019
03
Conditions
B-cell leukemia (BCL)B cell lymphoma
Beyond the preview
Go deeper on NCT05932173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05932173.